|Title:||Potassium, sodium and tris oxaprozin salt pharmaceutical formulations|
|Abstract:||Pharmaceutical compositions containing potassium, sodium or Tris salt of oxaprozin as an active agent. The pharmaceutical compositions of the present invention are useful in eliminating or ameliorating pain and in the treatment of inflammation and inflammation associated disorders such as rheumatoid arthritis and osteoarthritis.|
|Inventor(s):||Adams; Mark E. (Evergreen Park, IL), Desai; Subhash (Grayslake, IL), Karim; Aziz (Skokie, IL), Paul; Kalidas (Skokie, IL), Schaaf; Douglas J. (Elgin, IL), Zold; David J. (Prospect Heights, IL)|
|Assignee:||G.D. Searle & Co. (Chicago, IL)|
Patent Claim Types:|
see list of patent claims
|Composition; Dosage form; Use;|
Field: Not categorized
Back Citations: 19th percentile
Forward Citations: 1st percentile
|Patent Number||Expiration Date|
|6,030,643||February 29, 2012|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Russian Federation||2197244||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.